ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
35 hedge funds and large institutions have $9.68M invested in Oncternal Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Holders
35
Holding in Top 10
–
Calls
$12K
Puts
$24K
Top Buyers
| 1 | +$9.56K | |
| 2 | +$8.55K | |
| 3 | +$7.56K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.56K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7K |
Top Sellers
| 1 | -$38.5K | |
| 2 | -$37.3K | |
| 3 | -$37K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$29K |